PLC Systems Announces Appointment of Louis Brenner, M.D. to Board of...( FRANKLIN Mass. June 4 /- PLC...),Health

FRANKLIN, Mass., June 4 /PRNewswire-FirstCall/ -- PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today announced the appointment of Louis Brenner, M.D. to the Company's Board of Directors. Dr. Brenner, currently Senior Vice President at AMAG Pharmaceuticals, Inc., fills the seat formerly held by Alan Magazine, who did not seek re-election.

Dr. Brenner, 39, brings to the PLC Board his expertise in the development and commercialization of clinically innovative technologies. At AMAG Pharmaceuticals, where he is a member of the Executive Committee, he has played a key role in the progress of the Company's lead product candidate. Prior to joining AMAG Pharmaceuticals in 2006, he spent four years at Genzyme Corporation, where he held several positions, including Senior Director of Business Development for the Renal and Transplantation Units. He is currently the Chairman of the Board of the National Kidney Foundation serving New England. Dr. Brenner holds a B.S. degree in Biology from Yale College, an M.D. degree from Duke University School of Medicine, and an M.B.A. degree from Harvard Business School. Dr. Brenner is Board Certified in Nephrology and Internal Medicine and cares for patients with kidney disease at Brigham and Women's Hospital in Boston. Dr. Brenner has published on a variety of Nephrology topics in leading scientific journals.

Mark R. Tauscher, President and Chief Executive Officer of PLC Systems, said, "We are very pleased to welcome Lou to our Board. His strong business experience in our sector adds a vital voice to our strategic planning. His expertise in Nephrology and continued work in this field will bolster our efforts to expand the launch of our innovative RenalGuard(R) technology, which is targeted at patients with diminished renal function who are undergoing imaging procedu
'/>"/>